News

IsoPlexis rallies $25 mln Series C

Branford, Connecticut-based IsoPlexis, a biotechnology company, has raised $25 million in Series C funding. Northpond Ventures led the round.

VC-backed companies sold for a median of 3.8x their invested capital in 2018, study finds

CinCor Pharma picks up $50 mln Series A

CinCor Pharma, a biopharmaceutical company, has secured $50 million in Series A funding. Sofinnova Investments led the round.

Collider Ventures gathers over $7.2 mln for $50 mln-targeted fund

Collider Ventures has raised over $7.2 million for its inaugural fund, according to an SEC filing. The target is $50 million. Collider is an early-stage blockchain and crypto-focused venture firm.

SamanTree Medical lands Series A funding

Lausanne, Switzerland-based SamanTree Medical, a spin-off company from the Swiss Federal Institute of Technology, has raised CHF 9.5 million in Series A financing. Panakès Partners led the round.

SamanTree Medical lands Series A funding

Lausanne, Switzerland-based SamanTree Medical, a spin-off company from the Swiss Federal Institute of Technology, has raised CHF 9.5 million in Series A financing. Panakès Partners led the round.

Rocketship.vc is seeking $120 mln towads second fund

Rocketship.vc is seeking $120 mln towads second fund

Sapphire Ventures to raise $150 mln opportunity fund

Sapphire Ventures has set out to raise a $150 million opportunity fund, according to a filing with the SEC.

Sapphire Ventures to raise $150 mln opportunity fund

Sapphire Ventures has set out to raise a $150 million opportunity fund, according to a filing with the SEC.